Table A1.
Panel Members
| Panel Member | Institution |
|---|---|
| M. Elizabeth H. Hammond, MD, FCAP, Co-Chair | Intermountain Healthcare, University of Utah School of Medicine, UT |
| Antonio C. Wolff, MD, FACP, Co-Chair | The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, MD |
| Daniel F. Hayes, MD, Co-Chair | University of Michigan Comprehensive Cancer Center, University of Michigan Health System, MI |
| D. Craig Allred, MD, FCAP, Steering Committee Member | Washington University School of Medicine in St Louis, MO |
| Mitch Dowsett, PhD, Steering Committee Member | Royal Marsden Hospital, United Kingdom |
| Sunil Badve, MD | Eastern Cooperative Oncology Group, Indiana University, IN |
| Robert L. Becker, MD, Ex-Officio | US Food and Drug Administration, Center for Devices and Radiological Health, Office of In Vitro Diagnostic Device Evaluation and Safety |
| Patrick L. Fitzgibbons, MD, FCAP | St. Jude Medical Center, CA |
| Glenn Francis, MBBS, FRCPA, MBA | Princess Alexandra Hospital, Australia |
| Neil S. Goldstein, MD, FCAP | Advanced Diagnostics Laboratory, MI |
| Malcolm Hayes, MD | University of British Columbia, Canada |
| David G. Hicks, MD, FCAP | University of Rochester, NY |
| Susan Lester, MD | Brigham and Women's Hospital, MA |
| Richard Love, MD | Ohio State University, OH |
| Lisa McShane, PhD | National Cancer Institute, Biometric Research Branch, Division of Cancer Treatment and Diagnosis, MD |
| Keith Miller, MD | UK NEQAS, United Kingdom |
| C. Kent Osborne, MD | Baylor College of Medicine, TX |
| Soonmyung Paik, MD | National Surgical Adjuvant Breast and Bowel Project, PA |
| Jane Perlmutter, PhD, Patient Representative | Gemini Group, MI |
| Anthony Rhodes, PhD | University of the West of England, Bristol, UK NEQAS |
| Hironobu Sasano, MD | Tohoku University School of Medicine, Japan |
| Jared N. Schwartz, MD, PhD, FCAP | Presbyterian Hospital, NC |
| Fred C.G.J. Sweep, PhD | Radboud University, Nijmegen, the Netherlands |
| Sheila Taube, PhD | ST Consulting, Glen Echo, MD |
| Emina Emilia Torlakovic, MD, PhD | Royal University Hospital, Saskatoon, Canada |
| Giuseppe Viale, MD, FRCPath | European Institute of Oncology, and University of Milan, Italy |
| Paul Valenstein, MD, FCAP | St. Joseph Mercy Hospital, Ann Arbor, MI |
| Daniel Visscher, MD | University of Michigan, Ann Arbor, MI |
| Thomas Wheeler, MD, FCAP | Baylor College of Medicine, TX |
| R. Bruce Williams, MD, FCAP | The Delta Pathology Group, Shreveport, LA |
| James L. Wittliff, MD, PhD | University of Louisville, KY |
| Judy Yost, MA, MT (ASCP), Ex Officio | CMS, Division of Laboratory Services (CLIA), MD |
Abbreviations: UK NEQAS, United Kingdom National External Quality Assessment Service; CMS, Centers for Medicare and Medicaid Services; CLIA, Clinical Laboratory Improvement Act.